Edifice Health

Imagine A World Without Chronic Disease

Business Model
B2B
Total Funding
$12.0M
Last Round
$12.0M Series AApr 2021
Rounds
1

About

Edifice Health enables patients to measure and monitor their inflammatory health, helping to proactively manage chronic inflammation for better overall health and longevity. The novel Inflammatory Age® test is derived from a 10 year NIH funded longitudinal research from Stanford University, the Stanford 1,000 Immunomes Project. Using state-of-the-art 'omics' platforms and advanced artificial intelligence methods, the Stanford team developed the world's first biomarker composite scoring system to measure inflammatory and immune health of an individual.

Summary

Edifice Health is a Biotech company. It has raised $12.0M in total across 1 round, most recently a $12.0M Series A round in Apr 2021. Investors include Leaps by Bayer, Paladin Capital Group and Ahren Innovation Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2021
$12.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Edifice Health on Indexed.vc
<a href="https://indexed.vc/companies/edifice-health"><img src="https://indexed.vc/api/badge/company/edifice-health" alt="Edifice Health on Indexed.vc" width="260" height="76" /></a>